Literature DB >> 7301046

Functional aspects and pathogenetic considerations of the neuropathy in the spontaneously diabetic BB-Wistar rat.

A A Sima, K Hay.   

Abstract

Electrophysiological features were studied longitudinally in the spontaneously diabetic insulin-dependent, BB-Wistar rat. These were correlated in time with the state of the patency of the protective barriers in peripheral nerves. Motor nerve conduction velocity was significantly slowed only 3 weeks after the onset of the diabetes. When ultrastructural changes began, the maximal conduction velocity was further diminished. The amplitudes of evoked muscle potentials and distal latencies were significantly altered in diabetic rats. No change in the permeability of the blood-nerve barrier could be demonstrated before, during or after the onset of the nerve conduction defect. The possible pathogenetic mechanisms are discussed and a possible mechanism is suggested, namely a reduced availability of energy to axons in diabetes.

Entities:  

Mesh:

Year:  1981        PMID: 7301046     DOI: 10.1111/j.1365-2990.1981.tb00237.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  11 in total

1.  Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.

Authors:  A A Sima; A Prashar; W X Zhang; S Chakrabarti; D A Greene
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 2.  Electrophysiology and morphology of myelinated nerve fibers. IV. Nodal function of pathological nerve fibers.

Authors:  T Brismar
Journal:  Experientia       Date:  1983-09-15

Review 3.  The diabetic syndrome of the 'BB' Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man.

Authors:  E B Marliss; A F Nakhooda; P Poussier; A A Sima
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

4.  Distal symmetric polyneuropathy in the spontaneously diabetic BB-wistar rat. An ultrastructural and teased fiber study.

Authors:  A A Sima; A C Lorusso; P Thibert
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

5.  Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.

Authors:  D A Greene; S Chakrabarti; S A Lattimer; A A Sima
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.

Authors:  A A Sima; S A Lattimer; S Yagihashi; D A Greene
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

7.  Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.

Authors:  M J Stevens; S A Lattimer; M Kamijo; C Van Huysen; A A Sima; D A Greene
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

8.  Altered metabolic incorporation of fucose and leucine into PNS myelin of 25-week-old diabetic (C57BL/Ks [db/db]) mice: effects of untreated diabetes on nerve metabolism.

Authors:  M G Chez; R G Peterson
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

9.  The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

Authors:  M J Stevens; J Dananberg; E L Feldman; S A Lattimer; M Kamijo; T P Thomas; H Shindo; A A Sima; D A Greene
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 10.  Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult.

Authors:  Andrew P Mizisin; Ananda Weerasuriya
Journal:  Acta Neuropathol       Date:  2010-12-07       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.